Evidence map›Paper›PMID 30512203›Full record

ArticleStem cells (Dayton, Ohio)2019

Endothelial Differentiation G Protein-Coupled Receptor 5 Plays an Important Role in Induction and Maintenance of Pluripotency.

Irina Neganova, Lewis Cotts, Peter Banks, Katja Gassner, Anvar Shukurov, Lyle Armstrong, Graham Ladds, Majlinda Lako

Open access · hybridAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Irina NeganovaInternational Centre for Life, Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Lewis CottsInternational Centre for Life, Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Peter BanksHigh Throughput Screening Facility, Medical School, Newcastle, United Kingdom.
Katja GassnerInternational Centre for Life, Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Anvar ShukurovSchool of Mathematics and Statistics, Newcastle University, Newcastle upon Tyne, United Kingdom.
Lyle ArmstrongInternational Centre for Life, Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.
Graham LaddsDepartment of Pharmacology, University of Cambridge, Cambridge, United Kingdom.
Majlinda LakoInternational Centre for Life, Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom.ORCID 0000-0003-1327-8573
Centre for Life · GBHigh Throughput Biology (United States) · USNewcastle University · GBUniversity of Cambridge · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M00015X/2European Research Council 614620Medical Research Council MR/R011338/1
6 · The paper itself

Abstract

Direct reprogramming of human somatic cells toward induced pluripotent stem cells holds great promise for regenerative medicine and basic biology. We used a high-throughput small interfering RNA screening assay in the initiation phase of reprogramming for 784 genes belonging to kinase and phosphatase families and identified 68 repressors and 22 effectors. Six new candidates belonging to the family of the G protein-coupled receptors (GPCRs) were identified, suggesting an important role for this key signaling pathway during somatic cell-induced reprogramming. Downregulation of one of the key GPCR effectors, endothelial differentiation GPCR5 (EDG5), impacted the maintenance of pluripotency, actin cytoskeleton organization, colony integrity, and focal adhesions in human embryonic stem cells, which were associated with the alteration in the RhoA-ROCK-Cofilin-PAXILLIN-actin signaling pathway. Similarly, downregulation of EDG5 during the initiation stage of somatic cell-induced reprogramming resulted in alteration of cytoskeleton, loss of human-induced pluripotent stem cell colony integrity, and a significant reduction in partially and fully reprogrammed cells as well as the number of alkaline phosphatase positive colonies at the end of the reprogramming process. Together, these data point to an important role of EDG5 in the maintenance and acquisition of pluripotency. Stem Cells 2019;37:318-331.

Indexed as

Cellular ReprogrammingDown-RegulationSignal TransductionCell LineHuman Embryonic Stem CellsHumansInduced Pluripotent Stem CellsSphingosine-1-Phosphate ReceptorsS1PR2 protein, humanSphingosine-1-Phosphate ReceptorsCytoskeletonEDG5Genome-wide RNAi screenGPCRhESCs/hiPSCsHuman somatic cell reprogramming

Identifiers

PMID30512203
PMCPMC6446721
OpenAlexW2913267419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.